Global Stock News

Reassessing Abbott Laboratories (ABT) After A 32% One Year Share Price Decline

Reassessing Abbott Laboratories (ABT) After A 32% One Year Share Price Decline

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

  • If you are wondering whether Abbott Laboratories at around US$87.41 is a bargain or a value trap, it helps to step back and look at what the current price really implies.

  • The stock has gained 3.5% over the past week, although it remains down 4.7% over the past month and has declined 29.6% year to date and 32.1% over the last year, which may have shifted how investors view its risk and potential reward.

  • Recent coverage has focused on Abbott Laboratories as a large healthcare stock with a long operating history, which keeps it on the radar for investors tracking established medical device and diagnostics…

Source link

Share this article

Scroll to Top